semaglutide covered by medi cal GLP-1 for Weight Loss Medi-Cal GLP-1 Weight Loss Medication

Most side effects are mild and temporary

Ozempic is a drug called semaglutide and is licensed to lower blood sugar levels in Type 2 diabetics (T2DM)

Similarly, breastfeeding is not recommended while on Rybelsus, as it's unknown if the medication passes into breast milk and could potentially affect a nursing infant

Cultural and religious dietary preferences should also be considered when planning protein sources

Semaglutide is typically available at a concentration of 1 mg per 0.05 mL, equating to 20 units per mg

While genetics influence your likelihood of side effects and their intensity, lifestyle factors and dose timing also matter